Are you one of the many Americans using GLP-1 drugs like Ozempic or Wegovy? Discover essential lifestyle tips to prevent nutrient deficiencies and muscle loss while maximizing your weight loss results!
Coca-Cola responds to Trump's claims about switching to cane sugar, defending its use of corn syrup and addressing health concerns related to obesity. The debate raises questions about the future of soft drinks in the U.S.
A groundbreaking study reveals that ultra-processed foods (UPFs) are sabotaging our metabolism, leading to weight gain despite exercise. Discover why the old adage of 'calories in, calories out' is misleading!
A new CDC report reveals that 1 in 3 adolescents aged 12-17 have prediabetes, raising alarms about rising obesity rates and future health risks. Experts urge lifestyle changes to combat this trend.
A new study reveals a troubling trend in American children's health, showing a significant increase in chronic conditions such as obesity, depression, and anxiety since 2007. Experts warn of worsening outcomes due to healthcare disparities and policy changes.
In a groundbreaking study, Stanford researchers reveal that heart attack deaths have plummeted by 89% since 1970, but deaths from other heart conditions like heart failure and irregular heartbeats are surging. Discover the alarming new trends in heart disease mortality.
Explore groundbreaking health trends from exosome treatments and HIV prevention injections to new obesity pills and brain implants. What do experts really think? Dive into the latest in health innovation and skepticism.
A groundbreaking study shows that bariatric surgery leads to five times more weight loss than GLP-1 drugs like semaglutide. Discover why surgery remains the gold standard in obesity treatment.
Appendix cancer diagnoses are on the rise, particularly among younger adults. Experts are puzzled by this trend and urge awareness of vague symptoms that could indicate this rare disease. Learn more about the potential causes and prevention strategies.
A new regulator confirmation links Ozempic to a rare eye condition, NAION, affecting diabetes patients. This revelation raises concerns about potential blindness risks associated with semaglutide. Discover the implications for users.
